Top Markets
#1 Cortex Cortex +32.97%
#2 DexNet DexNet +23.20%
#3 龙虾 (Lobster) 龙虾 (Lobster) +19.81%
#4 wojak wojak +17.68%
#5 Pons Pons +15.94%
#6 Akedo Akedo +13.13%
#7 MarsCoin MarsCoin +9.56%
#8 OpenEden OpenEden +9.38%
#9 EXOD EXOD +9.04%
#10 BNB Attestation Service BNB Attestation Service +8.85%
Coin of the day
Cortex Cortex
Settings
Language
ENGLISH
Currency
USD
Theme
Pharma Mar, S.A. Pharma Mar, S.A.

Pharma Mar, S.A.

PHM
Rank in Stocks #7110
Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and... Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and headquartered in Madrid, Spain, is dedicated to the research, development, production, and global sale of marine-derived bioactive compounds. Its primary focus is oncology, with operations spanning Spain, Italy, Germany, Ireland, the wider European Union, the United States, and other international markets. The company's activities are organized into three key segments: Oncology, Diagnostics, and RNA interference. Among its developed and commercialized treatments are Yondelis, prescribed for soft tissue sarcomas and ovarian cancer; Aplidin, targeting multiple myeloma; and Zepzelca, used for patients with small cell lung cancer. Furthermore, Pharma Mar is advancing PM14, currently in Phase II clinical trials for various solid tumors. Beyond pharmaceuticals, the company manufactures and markets diagnostic kits and is involved in creating therapeutic drugs designed to reduce or silence gene expression.
Share Price
$99.16
Last synced: 2026-08-27
Market Cap
$1.72B
Change (1 day)
0.00%
Change (1 year)
2.52%
Country
ES
Trade Pharma Mar, S.A. (PHM)

Category

Healthcare
Earnings for Pharma Mar, S.A. (PHM)
Earnings in 2026 TTM: 0
According to Pharma Mar, S.A. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Pharma Mar, S.A. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH